Kura Oncology Announces Pricing of $100 Million Public Offering of Common Stock

    NEXT STORY
    1,767 Orion Corporation A shares converted into B shares
    PREV STORY
    Kura Oncology Announces Commencement of Public Offering of Common Stock
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Cellular Biomedicine Group Appoints CAR-T Pioneer Dr. Stephan A. Grupp as Member of Scientific Advisory Board

    SHANGHAI, China and NEW YORK, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group ...

    author_avatar
    NASDAQ Market News

    Hemispherx Reports Six Months Ended June 30, 2018 Financial Results and Provides Business Update

    OCALA, Fla., Aug. 15, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB), an ...

    author_avatar
    NASDAQ Market News

    Hemispherx to Present at the 4th Annual Immuno-Oncology: BD&L and Investment Forum

    ORLANDO, Fla., May 14, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB) announced ...

    author_avatar
    NASDAQ Market News